The global Food Safety Testing Market size was valued at USD 26.2 billion in 2025 and is projected to grow from USD 28.3 billion in 2026 to USD 48.0 billion by 2033, registering a CAGR of 7.8% from 2026 to 2033. Europe dominated the global market with a 34.1% revenue share in 2025, supported by stringent food safety regulations, advanced laboratory infrastructure, and high consumer...

The global genomics market size was estimated at USD 21.76 billion in 2025 and is projected to reach USD 72.50 billion by 2033, growing at a CAGR of 18.2% from 2026 to 2033. The market is experiencing rapid expansion due to increasing adoption of genomics technologies across healthcare, biotechnology, pharmaceuticals, and life science research applications. The growth is strongly...

The North America Proteinase K Market is witnessing robust expansion due to increasing research and development activities in biotechnology, pharmaceuticals, and molecular diagnostics across the region. Countries such as the United States and Canada are investing heavily in genomic research, personalized medicine, and advanced healthcare technologies, creating substantial opportunities for...

The global Liquid Biopsy Market size was estimated at USD 13.60 billion in 2025 and is projected to reach USD 32.57 billion by 2033, growing at a CAGR of 11.52% from 2026 to 2033. The market is experiencing significant growth due to the rising prevalence of cancer worldwide, rapid advancements in cancer diagnostics, and the increasing preference for minimally invasive testing methods....

The global Microfluidics Market was valued at USD 41.9 billion in 2025 and is projected to grow from USD 46.9 billion in 2026 to USD 105.1 billion by 2033, registering a CAGR of 12.2% from 2026 to 2033. North America accounted for the largest revenue share of 42.8% in 2025, driven by the rapid adoption of microfluidic technologies across diagnostics, biomedical research, drug...

The global qPCR Instruments Market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, registering a CAGR of 7.0% from 2026 to 2033. North America accounted for the largest revenue share of 40.9% in 2025, supported by advanced healthcare infrastructure, strong investments in molecular diagnostics, and widespread...

The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

The global agricultural biotechnology landscape in 2026 is experiencing a genomic revolution that is fundamentally transforming the speed, precision, and efficiency of crop and livestock improvement programs, with the Agrigenomics Market at the center of this transformation as genomic selection, high-throughput genotyping, and whole genome sequencing technologies enable breeding programs to...

The growing prevalence of bile duct cancer and the increasing demand for advanced oncology treatments are significantly contributing to the expansion of the global therapeutics market. Rising investments in cancer research, improved diagnostic technologies, and the introduction of targeted therapies are transforming the treatment landscape for cholangiocarcinoma, commonly known as bile duct...

BioMEMS integration with next-generation sequencing — providing the flow cells, fluidic channels, and optical detection architectures that enable massively parallel genomic sequencing — represents a foundational infrastructure contribution to the genomics revolution, with the BioMEMS Market reflecting BioMEMS' role in the commercial genomics market. Illumina flow cell BioMEMS...